BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 2000

View Archived Issues

Discovery of new generation of ribozymes and compound with potent activity against HER-2 oncogene

Read More

TAP and IPF PharmaCeuticals enter research collaboration

Read More

Basel Institute for Immunology to become a center for medical genomics with Roche support

Read More

AVI BioPharma and collaborators offer key findings for polycystic kidney disease drug development

Read More

Japanese launch of Dovonex ointment imminent

Read More

NovoLog granted FDA approval for treatment of diabetes mellitus

Read More

Interneuron updates clinical and regulatory plans for trospium

Read More

Neurocrine Biosciences advances obesity and diabetes research program

Read More

Bioniche uncovers new class of agents with anticancer activity

Read More

Rat studies demonstrate feasibility of AAV-TNFR:Fc gene therapy in rheumatoid arthritis

Read More

New tryptase inhibitor effective against allergic airways inflammation in animal model

Read More

ICN-10776 reported at Immunology 2000 to induce Th2 cytokine bias

Read More

Data presented this week on antiproliferative activity and mechanism of action of CT-3

Read More

Inflazyme receives investment; advances development programs

Read More

Preliminary pharmacological profile of NMI-377 presented at ASBMB/ASPET 2000

Read More

NO donors revealed as novel therapeutic agents for female sexual dysfunction

Read More

Calyx's new tyrphostin compound exerts both antidiabetic and antiinflammatory effects

Read More

GenVec receives payment for BioByPass milestone

Read More

New thiazole derivatives for inhibiting cell adhesion

Read More

New mGluR1 antagonists claimed by Lilly for migraine and CNS disorders

Read More

Alcon discovers utility of glutamate antagonists for retinal disorders

Read More

Rizatriptan + rofecoxib claimed by Merck for use in migraine

Read More

More effective, better tolerated combinations for migraine

Read More

Orally active and selective COX-2 inhibitors described by Abbott

Read More

Takeda patents new series of somatostatin receptor-modulating aromatic amines

Read More

Vanadium complexes with hypoglycemic and antiproliferative effects

Read More

Cytokine production inhibitors developed by SB for inflammatory disorders

Read More

Pfizer presents new ketolides and use for infections and cancer

Read More

Cortex receives funding to test CX-516 in patients with mild cognitive impairment

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing